|
Just an imo, fwiw comment on price. Historically, last few yrs, there has been an e3 price bulge. For the most part that didn't happen, unless you want to count the prior runup to 8. Anyway, in reviewing e3 I didn't get particular negatives about aklm, but no raves either. Don't you think the promising lineup accounted for part of the stock price. Apparently it didn't wow e3. Couple that with mediocre to worse news and we collapse below the recent gapup and below last year's two runups. Aklm broke down, again, and the only thing that will fix it is to prove that it is on the rebound and can maintain growth, which we must remember, it has been unable to do for quite awhile. If it breaks thru support here (200dma), it looks bleak, with tacit support at 4.75 and 4.25 before testing nasdaq delisting at 4. I'm long and wishing for the best but discouraged w/o upbeat earnings. If revenues/earnings are on the low side and it is still at 5, big time short and looking at 3. All my speculation. Have no problem with anyone explaining why I am wrong, because I would love to be. stx79 |
